Abstract
Background/Aim: Geranylgeranylacetone (GGA) enhances gastric mucosal protection against nonsteroidal anti-inflammatory drugs by upregulating mucosal heat shock proteins (HSP), but the effects of GGA on the human gastric mucosa have not been well examined. This study was conducted to determine whether a clinical dose of GGA protects the human gastric mucosa from diclofenac (DIC)-induced gastric mucosal injury. Methods: The study group comprised 40 healthy volunteers: 20 subjects were randomly assigned to take either placebo (lactose 1.5 g/day) or GGA (150 mg/day) for 2 weeks (study 1), and 20 subjects were assigned to take DIC (75 mg/day) plus placebo (lactose 1.5 g/day) or DIC (75 mg/day) plus GGA (150 mg/day) for 2 weeks (study 2). In both studies, gastroscopic biopsy specimens were obtained before and after treatment. Mucosal HSP70 expression and DNA damage were analyzed by measuring the levels of HSP70 and 8-oxo-7,8-dihydro-2′-deoxyguanosine (8-OHdG), respectively. Results: In study 1, GGA increased the mucosal HSP70 expression without increasing the 8-OHdG production. In study 2, DIC treatment increased the 8-OHdG production, whereas the combination of GGA and DIC enhanced the HSP70 expression and attenuated the increase in 8-OHdG induced by DIC. Conclusion: The clinical dose of GGA enhanced the gastric mucosal HSP70 expression and inhibited the DIC-induced gastric mucosal damage in humans.
Journal Section:
Original Paper
References
1.
Allen A, Flemstrom G, Garner A, Kivilaakso E: Gastroduodenal mucosal protection. Physiol Rev 1993;73:823–857.
[PubMed]
2.
Robert A, Nezamis JE, Lancaster C, Davis JP, Field SO, Hanchar AJ: Mild irritants prevent gastric necrosis through ‘adaptive cytoprotection’ mediated by prostaglandins. Am J Physiol 1983;245:G113–G121.
[PubMed]
3.
Schiessel R, Allison JG, Barzilai A, Fleischer LA, Matthews JB, Merhav A, Simson J, Silen W: Failure of 16-16-dimethyl-prostaglandin E2 to stimulate alkaline secretion in the isolated amphibian gastric mucosa. Gastroenterology 1980;78:1513–1517.
[PubMed]
4.
Miller TA, Henagan JM, Kuo YJ, Shanbour LL: Failure of 16,16-dimethyl PGE2 to prevent inhibitory effect of ethanol on sodium transport in canine gastric mucosa. Am J Physiol 1985;248(3 Pt 1):G299–G306.
[PubMed]
5.
Arakawa T, Nakamura H, Chono S, Satoh H, Fukuda T, Saeki Y, Kobayashi K: Absence of effect of 16,16-dimethyl prostaglandin E2 on reduction of gastric mucosal blood flow caused by indomethacin in rats. Dig Dis Sci 1989;34:1369–1373.
[PubMed]
6.
Nakamura K, Rokutan K, Marui N, Aoike A, Kawai K: Induction of heat shock proteins and their implication in protection against ethanol-induced damage in cultured guinea pig gastric mucosal cells. Gastroenterology 1991;101:161–166.
[PubMed]
7.
Feder ME, Hofmann GE: Heat-shock proteins, molecular chaperones, and the stress response: evolutionary and ecological physiology. Annu Rev Physiol 1999;61:243–282.
[PubMed]
8.
Leppa S, Sistonen L: Heat shock response – pathophysiological implications. Ann Med 1997;29:73–78.
[PubMed]
9.
Hirakawa T, Rokutan K, Nikawa T, Kishi K: Geranylgeranylacetone induces heat shock proteins in cultured guinea pig gastric mucosal cells and rat gastric mucosa. Gastroenterology 1996;111:345–357.
[PubMed]
10.
Ohkawara T, Nishihira J, Takeda H, Katsurada T, Kato K, Yoshiki T, Sugiyama T, Asaka M: Protective effect of geranylgeranylacetone on trinitrobenzene sulfonic acid-induced colitis in mice. Int J Mol Med 2006;17:229–234.
[PubMed]
11.
Nishida T, Matsura T, Nakada J, Togawa A, Kai M, Sumioka I, Minami Y, Inagaki Y, Ishibe Y, Ito H, Ohta Y, Yamada K: Geranylgeranylacetone protects against acetaminophen-induced hepatotoxicity by inducing heat shock protein 70. Toxicology 2006;219:187–196.
[PubMed]
12.
Uchida S, Fujiki M, Nagai Y, Abe T, Kobayashi H: Geranylgeranylacetone, a noninvasive heat shock protein inducer, induces protein kinase C and leads to neuroprotection against cerebral infarction in rats. Neurosci Lett 2006;396:220–224.
[PubMed]
13.
Ooie T, Takahashi N, Saikawa T, Nawata T, Arikawa M, Yamanaka K, Hara M, Shimada T, Sakata T: Single oral dose of geranylgeranylacetone induces heat-shock protein 72 and renders protection against ischemia/reperfusion injury in rat heart. Circulation 2001;104:1837–1843.
[PubMed]
14.
Russell RI: Non-steroidal anti-inflammatory drugs and gastrointestinal damage – problems and solutions. Postgrad Med J 2001;77:82–88.
[PubMed]
15.
Hawkey CJ: Nonsteroidal anti-inflammatory drug gastropathy. Gastroenterology 2000;119:521–535.
[PubMed]
16.
Tomisato W, Takahashi N, Komoto C, Rokutan K, Tsuchiya T, Mizushima T: Geranylgeranylacetone protects cultured guinea pig gastric mucosal cells from indomethacin. Dig Dis Sci 2000;45:1674–1679.
[PubMed]
17.
Ushijima H, Tanaka K, Takeda M, Katsu T, Mima S, Mizushima T: Geranylgeranylacetone protects membranes against nonsteroidal anti-inflammatory drugs. Mol Pharmacol 2005;68:1156–1161.
[PubMed]
18.
Walsh RC, Koukoulas I, Garnham A, Moseley PL, Hargreaves M, Febbraio MA: Exercise increases serum Hsp72 in humans. Cell Stress Chaperones 2001;6:386–393.
[PubMed]
19.
Jew KN, Moore RL: Glibenclamide improves postischemic recovery of myocardial contractile function in trained and sedentary rats. J Appl Physiol 2001;91:1545–1554.
[PubMed]
20.
Gambero A, Becker TL, Zago AS, de Oliveira AF, Pedrazzoli J Jr: Comparative study of anti-inflammatory and ulcerogenic activities of different cyclo-oxygenase inhibitors. Inflammopharmacology 2005;13:441–454.
[PubMed]
21.
Ishihara K, Yamagishi N, Hatayama T: Suppression of heat- and polyglutamine-induced cytotoxicity by nonsteroidal anti-inflammatory drugs. Eur J Biochem 2004;271:4552–4558.
[PubMed]
22.
Batulan Z, Nalbantoglu J, Durham HD: Nonsteroidal anti-inflammatory drugs differentially affect the heat shock response in cultured spinal cord. Cell Stress Chaperones 2005;10:185–196.
[PubMed]
23.
Murakami M, Oketani K, Fujisaki H, Wakabayashi T, Ohgo T, Okabe S: Effects of the antiulcer drug geranylgeranylacetone on aspirin-induced gastric ulcers in rats. Jpn J Pharmacol 1982;32:299–306.
[PubMed]
24.
Nagasawa Y, Tatsuta M, Iishi H, Ishiguro S: Prevention of gastric ulcer recurrence with tetraprenylacetone. Scand J Gastroenterol 1998;33:44–48.
[PubMed]
25.
Terano A, Hiraishi H, Ota S, Sugimoto T: Geranylgeranylacetone, a novel anti-ulcer drug, stimulates mucus synthesis and secretion in rat gastric cultured cells. Digestion 1986;33:206–210.
[PubMed]
26.
Tanaka K, Tsutsumi S, Arai Y, Hoshino T, Suzuki K, Takaki E, Ito T, Takeuchi K, Nakai A, Mizushima T: Genetic evidence for a protective role of heat shock factor 1 against irritant-induced gastric lesions. Mol Pharmacol 2007;71:985–993.
[PubMed]
27.
Hawkey CJ, Karrasch JA, Szczepanski L, Walker DG, Barkun A, Swannell AJ, Yeomans ND: Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-Induced Ulcer Management (OMNIUM) Study Group. N Engl J Med 1998;338:727–734.
[PubMed]
© 2007 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2007
You do not currently have access to this content.
